Regenerative therapy for hypoplastic left heart syndrome: First report of intraoperative intramyocardial injection of autologous umbilical-cord blood–derived cells  Harold M. Burkhart, MD, Muhammad Yasir Qureshi, MBBS, Susana Cantero Peral, MD, Patrick W. O'Leary, MD, Timothy M. Olson, MD, Frank Cetta, MD, Timothy J. Nelson, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 149, Issue 3, Pages e35-e37 (March 2015) DOI: 10.1016/j.jtcvs.2014.10.093 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Apical views of echocardiogram performed before (top panels) and 3 months after (bottom panels) intramyocardial injection of umbilical-cord blood–derived stem cells. Images show improvement in right ventricular function, with an increase in the ejection fraction from 30%-35% to 50%. FAC, Fractional area change; EF, ejection fraction. The Journal of Thoracic and Cardiovascular Surgery 2015 149, e35-e37DOI: (10.1016/j.jtcvs.2014.10.093) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions